NCT00657202
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cutaneous Neurofibromas, Genetic Diseases, Inborn, +17 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Clinical trial condition
Neurofibromatosis 1
Explore clinical trials studying Neurofibromatosis 1. Study availability and eligibility vary by location and protocol.
133 public trials
21 recruiting studies
Neurofibromatosis 1 trial results
NCT01851135
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
- Locations
-
- Assistance Publique - Hôpitaux de Paris (Hôpital Henri Mondor) Créteil, France
- Centre Hospitalier Universitaire de Nantes Nantes, France
NCT02298270
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +30 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Completed
Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
NCT00589784
- Conditions
- Brain Diseases, Brain Neoplasms, CNS Cancer, +42 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT02479360
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
- Locations
-
- Neurofibromatosis Unit, Guys Hospital. London, United Kingdom
NCT02422732
- Conditions
- Communication Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslexia, +25 more
- Locations
-
- CHU Toulouse Toulouse, France
Completed
Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
NCT00053937
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +19 more
- Locations
-
- University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
- Children's Memorial Hospital - Chicago Chicago, Illinois, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
Completed
Reading Disability in Children With NF1
NCT02397967
- Conditions
- Communication Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslexia, +25 more
- Locations
-
- Hopital femme-mére-enfant, Hospices civils de lyon Lyon, France
- Hôpital Gui de Chauliac Montpellier, France
- CHU Hôtel-Dieu, Clinic of Dermatology Nantes, France
- AP-HP Hopital Armand Trousseau Paris, France
NCT01412892
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
- Locations
-
- Henri Mondor Hospital Créteil, France
NCT00352495
- Conditions
- Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +32 more
- Locations
-
- Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States
- Children's Hospital of Orange County Orange, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
- Children's Memorial Hospital - Chicago Chicago, Illinois, United States
Related conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (133)
- Heredodegenerative Disorders, Nervous System (133)
- Neoplasms by Histologic Type (133)
- Neoplasms, Nerve Tissue (133)
- Neoplastic Syndromes, Hereditary (133)
- Nervous System Diseases (133)
- Neurodegenerative Diseases (133)
- Neuromuscular Diseases (133)